27 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
1732545	27	Phenyl-substituted analogues of oxotremorine as muscarinic antagonists.	University of Uppsala
1995893	81	Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships.	Ferrosan
2299626	18	Beta-lactam analogues of oxotremorine. 3- and 4-methyl-substituted 2-azetidinones.	University of Uppsala
2258904	21	Resolved pyrrolidine, piperidine, and perhydroazepine analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.	Uppsala University
3346873	24	Derivatives of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.	University of Uppsala
3336015	8	Dimethylsulfonium and thiolanium analogues of the muscarinic agent oxotremorine.	University of California
3494849	3	6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.	TBA
14998318	112	Selective optimization of side activities: another way for drug discovery.	Prestwick Chemical
1956033	121	Synthesis, molecular modeling studies, and muscarinic receptor activity of azaprophen analogues.	Research Triangle Institute
2153827	12	Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.	Niddk
	32	The synthesis and biological activity of some known and putative metabolites of the atypical antipsychotic agent olanzapine (LY170053)	TBA
	37	The discovery of CP-96,021 and CP-96,486, balanced, combined, potent and orally active leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor antagonists.	TBA
	31	3-Lithioquinuclidin-2-ene: A novel intermediate for the synthesis of muscarinic agonists and antagonists	TBA
	74	New indole derivatives as potent and selective serotonin uptake inhibitors	TBA
16722631	87	An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.	Predix Pharmaceuticals
16458504	37	Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: a novel agonist 5-HT1A receptor PET ligand.	Columbia University College of Physicians and Surgeons
16392798	46	Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.	Columbia University College of Physicians and Surgeons
14643338	124	Binding of beta-carbolines at 5-HT(2) serotonin receptors.	Virginia Commonwealth University
16153841	24	Activity and QSAR study of baogongteng A and its derivatives as muscarinic agonists.	Shanghai Second Medical University
9371246	159	Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.	Uppsala University
8765510	100	3-(2-Benzofuranyl)quinuclidin-2-ene derivatives: novel muscarinic antagonists.	Uppsala University
3712371	49	A novel class of conformationally restricted heterocyclic muscarinic agonists.	TBA
30052039	172	Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME Properties.	Emory University
29795757	100	Discovery of	Emory University
29348805	56	Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists.	Emory University
1674541	24	Conformational properties of semirigid antipsychotic drugs: the pharmacophore for dopamine D-2 antagonist activity.	Harvard Medical School